Literature DB >> 7531497

Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney.

M Li1, H Guo, Z Damuni.   

Abstract

Two heat-stable protein inhibitors of protein phosphatase 2A (PP2A), tentatively designated I1PP2A and I2PP2A, have been purified to apparent homogeneity from extracts of bovine kidney. The purified preparations of I1PP2A exhibited an apparent M(r) approximately 30,000 and 250,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel permeation chromatography on Sephacryl S-300, respectively. In contrast, the purified preparations of I2PP2A exhibited an apparent M(r) approximately 20,000 and 80,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel permeation chromatography on Sephacryl S-200, respectively. The purified preparations of I1PP2A and I2PP2A inhibited PP2A with 32P-labeled myelin basic protein, 32P-labeled histone H1, 32P-labeled pyruvate dehydrogenase complex, 32P-labeled phosphorylase, and protamine kinase as substrates. By contrast, I1PP2A and I2PP2A exhibited little effect, if any, on the activity of PP2A with 32P-labeled casein, and did not prevent the autodephosphorylation of PP2A in incubations with the autophosphorylation-activated protein kinase [Guo, H., & Damuni, Z. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 2500-2504]. The purified preparations of I1PP2A and I2PP2A had little effect, if any, on the activities of protein phosphatase 1, protein phosphatase 2B, protein phosphatase 2C, and pyruvate dehydrogenase phosphatase. With 32P-labeled MBP as a substrate, kinetic analysis according to Henderson showed that I1PP2A and I2PP2A were noncompetitive and displayed a Ki of about 30 and 25 nM, respectively. Following cleavage with Staphylococcus aureus V8 protease, I1PP2A and I2PP2A displayed distinct peptide patterns, indicating that these inhibitor proteins are the products of distinct genes. The N-terminal amino acid sequences of the purified preparations indicate that I1PP2A and I2PP2A are novel proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531497     DOI: 10.1021/bi00006a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  82 in total

1.  Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells.

Authors:  S Endo; M Suzuki; M Sumi; A C Nairn; R Morita; K Yamakawa; P Greengard; M Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.

Authors:  Patrick T Reilly; Yun Yu; Ali Hamiche; Lishun Wang
Journal:  Bioessays       Date:  2014-08-25       Impact factor: 4.345

3.  Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Authors:  Archana Mukhopadhyay; Kayann Tabanor; Rathnam Chaguturu; Jane V Aldrich
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

4.  The N-terminal Set-β Protein Isoform Induces Neuronal Death.

Authors:  Ephraim F Trakhtenberg; Melina I Morkin; Karan H Patel; Stephanie G Fernandez; Alan Sang; Peter Shaw; Xiongfei Liu; Yan Wang; Gregory M Mlacker; Han Gao; Dmitry Velmeshev; Susan M Dombrowski; Michael P Vitek; Jeffrey L Goldberg
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

5.  The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.

Authors:  Matthew J Gamble; Hediye Erdjument-Bromage; Paul Tempst; Leonard P Freedman; Robert P Fisher
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET.

Authors:  Jean Paul ten Klooster; Ingrid v Leeuwen; Nina Scheres; Eloise C Anthony; Peter L Hordijk
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

7.  Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.

Authors:  Otto Kauko; Susumu Y Imanishi; Evgeny Kulesskiy; Laxman Yetukuri; Teemu Daniel Laajala; Mukund Sharma; Karolina Pavic; Anna Aakula; Christian Rupp; Mikael Jumppanen; Pekka Haapaniemi; Luyao Ruan; Bhagwan Yadav; Veronika Suni; Taru Varila; Garry L Corthals; Jüri Reimand; Krister Wennerberg; Tero Aittokallio; Jukka Westermarck
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

8.  TFIIIB is phosphorylated, disrupted and selectively released from tRNA promoters during mitosis in vivo.

Authors:  Jennifer A Fairley; Pamela H Scott; Robert J White
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

Review 9.  Novel therapeutic strategies for neurodegenerative disease.

Authors:  Hitoshi Tanimukai; Takashi Kudo; Toshihisa Tanaka; Inge Grundke-Iqbal; Khalid Iqbal; Masatoshi Takeda
Journal:  Psychogeriatrics       Date:  2009-06       Impact factor: 2.440

Review 10.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.